Results 131 to 140 of about 57,366 (267)
Intranasal administration of broad-spectrum macrocyclic peptide inhibitor protects against SARS-CoV-2 Omicron variants. [PDF]
Wang M +23 more
europepmc +1 more source
ABSTRACT Endoscopic orbital surgery is likely a reasonable option for patients with orbital cavernous hemangiomas (OCH) medial to the optic nerve (ON). The endoscopic resection of OCH lateral to the ON is extremely challenging. Zhou et al. first described the endoscopic prelacrimal recess approach (PLRA) for the management of the maxillary sinus and ...
Zhen‐Xiao Huang +2 more
wiley +1 more source
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration. [PDF]
Wu H, Li C, Yuan H, Zhao J, Li S.
europepmc +1 more source
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews +3 more
wiley +1 more source
Oral and Intranasal Administration of Polydeoxyribonucleotide Isolated from <i>Porphyra</i> sp. Ameliorates Acute Lung Injury via Suppressing Proinflammatory Cytokine Production in Mice. [PDF]
Lee GY, Lee WS, Han J, Yoo YC.
europepmc +1 more source
Intranasal Administration of Mammary Tumour Milk Factor [PDF]
openaire +2 more sources
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian +3 more
wiley +1 more source
Quantitation of Cannabidiol (CBD) in brain regions and plasma following intranasal administration of a CBD nanoformulation. [PDF]
Upadhyay G +3 more
europepmc +1 more source
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden +10 more
wiley +1 more source
Interstitial granulomatous drug reaction after intranasal desmopressin administration
Maione, Vincenzo +3 more
openaire +2 more sources

